1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MERCK & CO INC
Merck & Co Inc XNYS: MRK

Merck & Company Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor t...

Read More
107.31 -0.87 (-0.80%)
Near 52W High of $112.90
4.8M
XNYS Volume

XNYS 26 Jan, 2026 2:00 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Merck & Company is on 04 Feb 2026 for the purpose of Merck & Co Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Affordable Valuation
52.3 / 100
Momentum Score
Technically Moderately Bullish
60.3 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors View Similar Embed DVM
Analyst Price Target
116
1Yr Price target upside is 8%
27 analysts

14

S

4

W

4

O

2

T

SWOT Analysis

Merck & Company Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..